Arcagy/ Gineco Group
Clinical trials sponsored by Arcagy/ Gineco Group, explained in plain language.
-
When is the best time for ovarian cancer surgery? new trial investigates
Disease control CompletedThis study looked at 211 women with advanced ovarian cancer who were not candidates for immediate surgery. It compared having surgery after 3 rounds of chemotherapy versus after 6 rounds. The goal was to see which approach leads to longer time without the cancer coming back.
Phase: NA • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Could adding an immunotherapy drug to chemo help fight advanced ovarian cancer?
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy before surgery helps shrink advanced ovarian cancer more than chemo alone. About 91 women with stage IV ovarian cancer took part. The goal was to see if the combination allow…
Phase: PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
1500 ovarian cancer patients studied to unlock genetic secrets
Knowledge-focused CompletedThis study looked at 1500 women with advanced ovarian, peritoneal, or fallopian tube cancer to see how their genes affect the disease. Researchers collected tumor samples and medical records to find links between genetic changes and how long patients stayed cancer-free. No new tr…
Sponsor: ARCAGY/ GINECO GROUP • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC